Development and Validation of Confocal Endomicroscopy Diagnostic Criteria for Low-Grade Dysplasia in Barrett's Esophagus.


Journal

Clinical and translational gastroenterology
ISSN: 2155-384X
Titre abrégé: Clin Transl Gastroenterol
Pays: United States
ID NLM: 101532142

Informations de publication

Date de publication:
04 2019
Historique:
pubmed: 16 4 2019
medline: 4 8 2020
entrez: 16 4 2019
Statut: ppublish

Résumé

Low-grade dysplasia (LGD) in Barrett's esophagus (BE) is generally inconspicuous on conventional and magnified endoscopy. Probe-based confocal laser endomicroscopy (pCLE) provides insight into gastro-intestinal mucosa at cellular resolution. We aimed to identify endomicroscopic features and develop pCLE diagnostic criteria for BE-related LGD. This was a retrospective study on pCLE videos generated in 2 prospective studies. In phase I, 2 investigators assessed 30 videos to identify LGD endomicroscopic features, which were then validated in an independent video set (n = 25). Criteria with average accuracy >80% and interobserver agreement κ > 0.4 were taken forward. In phase II, 6 endoscopists evaluated the criteria in an independent video set (n = 57). The area under receiver operating characteristic curve was constructed to find the best cutoff. Sensitivity, specificity, interobserver, and intraobserver agreements were calculated. In phase I, 6 out of 8 criteria achieved the agreement and accuracy thresholds (i) dark nonround glands, (ii) irregular gland shape, (iii) lack of goblet cells, (iv) sharp cutoff of darkness, (v) variable cell size, and (vi) cellular stratification. The best cutoff for LGD diagnosis was 3 out of 6 positive criteria. In phase II, the diagnostic criteria had a sensitivity and specificity for LGD of 81.9% and 74.6%, respectively, with an area under receiver operating characteristic of 0.888. The interobserver agreement was substantial (κ = 0.654), and the mean intraobserver agreement was moderate (κ = 0.590). We have generated and validated pCLE criteria for LGD in BE. Using these criteria, pCLE diagnosis of LGD is reproducible and has a substantial interobserver agreement.

Identifiants

pubmed: 30985335
doi: 10.14309/ctg.0000000000000014
pmc: PMC6602783
doi:

Types de publication

Journal Article Research Support, Non-U.S. Gov't Validation Study

Langues

eng

Sous-ensembles de citation

IM

Pagination

e00014

Subventions

Organisme : Medical Research Council
ID : MC_UU_12022/2
Pays : United Kingdom

Références

Gastrointest Endosc. 2011 Sep;74(3):465-72
pubmed: 21741642
Gut. 2012 Jul;61(7):970-6
pubmed: 21997553
Gastrointest Endosc. 2012 Aug;76(2):252-4
pubmed: 22817781
Am J Gastroenterol. 2011 Nov;106(11):1961-9
pubmed: 21946283
Gut. 2002 Jul;51(1):130-1
pubmed: 12077106
Gastrointest Endosc. 2016 Apr;83(4):684-98.e7
pubmed: 26874597
J Natl Cancer Inst. 2011 Jul 6;103(13):1049-57
pubmed: 21680910
Gut. 2018 Feb;67(2):392-393
pubmed: 28389530
Dig Dis Sci. 2013 Jun;58(6):1703-9
pubmed: 23633158
Am J Gastroenterol. 2016 Jan;111(1):30-50; quiz 51
pubmed: 26526079
Dig Dis Sci. 2013 Jan;58(1):188-93
pubmed: 22875309
Gut. 2015 May;64(5):700-6
pubmed: 25034523
World J Gastroenterol. 2013 Sep 28;19(36):6011-9
pubmed: 24106401
Gut. 2016 Apr;65(4):555-62
pubmed: 25731874
JAMA. 2014 Mar 26;311(12):1209-17
pubmed: 24668102
Clin Exp Gastroenterol. 2014 May 13;7:133-50
pubmed: 24868168
Gut. 2014 Jan;63(1):7-42
pubmed: 24165758
Gastroenterology. 2011 Oct;141(4):1179-86, 1186.e1
pubmed: 21723218
N Engl J Med. 2011 Oct 13;365(15):1375-83
pubmed: 21995385
Clin Gastroenterol Hepatol. 2009 Jul;7(7):736-42; quiz 710
pubmed: 19268726
Am J Gastroenterol. 2015 Nov;110(11):1549-58
pubmed: 26416188
Gastrointest Endosc. 2008 Mar;67(3):394-8
pubmed: 18045592

Auteurs

Massimiliano di Pietro (M)

MRC Cancer Unit, University of Cambridge, Cambridge, United Kingdom.

Helga Bertani (H)

Digestive Endoscopy Unit, Baggiovara, Azienda Ospedaliero-Universitaria di Modena, Italy.

Maria OʼDonovan (M)

Department of Histopathology, Cambridge University Hospitals, Cambridge, United Kingdom.

Patricia Santos (P)

MRC Cancer Unit, University of Cambridge, Cambridge, United Kingdom.

Hani Alastal (H)

MRC Cancer Unit, University of Cambridge, Cambridge, United Kingdom.
Life Sciences, University of South Wales, Pontypridd, Wales.

Richard Phillips (R)

MRC Cancer Unit, University of Cambridge, Cambridge, United Kingdom.

Jacobo Ortiz-Fernández-Sordo (J)

NIHR Nottingham Digestive Diseases Biomedical Research Centre, Nottingham University Hospitals NHS Trust and the University of Nottingham, Nottingham, United Kingdom.

Marietta Iacucci (M)

Institute of Translational of Medicine and NIHR Biomedical Research Centre, University of Birmingham, United Kingdom.

Ines Modolell (I)

Department of Gastroenterology, Cambridge University Hospitals, Cambridge, United Kingdom.

Luca Reggiani Bonetti (L)

Department of Pathology, Policlinico di Modena, University of Modena and Reggio Emilia, Modena, Italy.

Krish Ragunath (K)

NIHR Nottingham Digestive Diseases Biomedical Research Centre, Nottingham University Hospitals NHS Trust and the University of Nottingham, Nottingham, United Kingdom.

Lorenz Wernisch (L)

MRC Biostatistics Unit, University of Cambridge, Cambridge, United Kingdom.

Articles similaires

[Redispensing of expensive oral anticancer medicines: a practical application].

Lisanne N van Merendonk, Kübra Akgöl, Bastiaan Nuijen
1.00
Humans Antineoplastic Agents Administration, Oral Drug Costs Counterfeit Drugs

Smoking Cessation and Incident Cardiovascular Disease.

Jun Hwan Cho, Seung Yong Shin, Hoseob Kim et al.
1.00
Humans Male Smoking Cessation Cardiovascular Diseases Female
Humans United States Aged Cross-Sectional Studies Medicare Part C
1.00
Humans Yoga Low Back Pain Female Male

Classifications MeSH